Keisuke Hikosaka

1.0k citations
15 papers · 791 indexed · h-index 9
Topics
Sirtuins and Resveratrol in Medicine (7 papers)PARP inhibition in cancer therapy (4 papers)Autophagy in Disease and Therapy (3 papers)

In The Last Decade

Keisuke Hikosaka

15 papers receiving 784 citations

Peers

Keisuke Hikosaka
Comparison fields: 5 of 102
  • Molecular Biology 275
  • Geriatrics and Gerontology 216
  • Materials Chemistry 212
  • Oncology 147
  • Physiology 135
Replace Mi Young Kim with:
Mi Young Kim South Korea
Yan‐Hong Jiang China
Xingmei Zhang China
Ljubica Vučićević Serbia
Maja Misirkić Serbia
Alexander Varvak Israel
Yingying Hu China
Deyi Zhang China
Xiaoshan Liang China
Koji Nagasawa Japan
Keisuke Hikosaka relative to Mi Young Kim South Korea Mi Young Kim's profile →
Citations per field
00.5×1.5×2.1×
Mi Young Kim · 1×
Citations per year

Countries citing papers authored by Keisuke Hikosaka

Since Specialization
Citations

This map shows the geographic impact of Keisuke Hikosaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Hikosaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Hikosaka more than expected).

Fields of papers citing papers by Keisuke Hikosaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Hikosaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Hikosaka. The network helps show where Keisuke Hikosaka may publish in the future.

Co-authorship network of co-authors of Keisuke Hikosaka

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Hikosaka. A scholar is included among the top collaborators of Keisuke Hikosaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Hikosaka. Keisuke Hikosaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 5
2 55
3 47
4 162
5 34
6 58
7 3
8 65
9 7
10 6
11 14
12 1
13
LIVE IMAGING BY TIME-LAPSE MICROSCOPY CAN MORE CLEARLY EVALUATE THE ANTI-APOPTOTIC STATE OF PRIMARY HEPATOCYTES ISOLATED FROM THE DRS KNOCKOUT MOUSE
1
14 77
15 256

About Keisuke Hikosaka

Keisuke Hikosaka is a scholar working on Geriatrics and Gerontology, Physiology and Hepatology, having authored 15 papers that have together received 791 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (7 papers), PARP inhibition in cancer therapy (4 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Geriatrics and Gerontology (216 citations), Physiology (135 citations) and Biological Psychiatry (37 citations). Keisuke Hikosaka has collaborated with scholars based in Japan, Switzerland and United States. Frequent co-authors include Takashi Nakagawa, Keisuke Yaku, Masashi Kajita, Yusei Miyamoto, Atsuhiro Kanayama, Keisuke Okabe, Naoki Toshima, Kazuyuki Tobe, Juewon Kim and Masashi Yamamoto. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026